Skip to content

Efficacy and Safety of Flurbiprofen Axetil Injection Combined with Ultrasound-Guided Intercostal Nerve Block for Preoperative Analgesia in Traumatic Rib Fractures: A Randomized Controlled Trial

Efficacy and Safety of Flurbiprofen Axetil Injection Combined with Ultrasound-Guided Intercostal Nerve Block for Preoperative Analgesia in Traumatic Rib Fractures: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500105786
Enrollment
Unknown
Registered
2025-07-10
Start date
2024-03-22
Completion date
Unknown
Last updated
2025-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute multiple rib fractures

Interventions

Experimental group:Experimental Group: Patients were given 50 mg of flurbiprofen axetil injection via slow intravenous infusion over more than 5 minutes. Initially, 30 mg was administered, and after o
Control group 1:Control Group 1: Patients were given 50 mg of flurbiprofen axetil injection via slow intravenous infusion over more than 5 minutes. Initially, 30 mg was administered, and after observi
Control group 2:Control Group 2: Patients were given an equal volume of normal saline as the flurbiprofen axetil injection used in the experimental group, administered in two intravenous injections. U

Sponsors

Foshan Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Adult patients aged >=18 and <=75 years with rib fractures due to chest trauma awaiting open reduction and internal fixation of rib fractures.

Exclusion criteria

Exclusion criteria: 1. ASA >= 4, 2. body weight less than 50 kg, 3. body mass index BMI > 35 kg/m^2, 4. presence of paradoxical respiration, 5. need for tracheal intubation and assisted ventilation, 6. history of allergy to flurbiprofen axetil injection or ropivacaine, 7. inability to understand and express the VAS score.

Design outcomes

Primary

MeasureTime frame
Subjective pain score VAS at rest 30 minutes after the completion of intercostal nerve block;

Secondary

MeasureTime frame
Oxygenation index of the patient 30 minutes after the intervention;Diaphragmatic excursion of the patient 30 minutes after the intervention;Patient satisfaction score 30 minutes after the intervention; Incidence of analgesic failure VAS score >3 at rest 30 minutes after the intervention ;VAS pain score at rest 6 hours after the intervention;VAS pain score at rest 12 hours after the intervention;VAS pain score at rest 18 hours after the intervention;VAS pain score at rest 24 hours after the intervention;Incidence of adverse events within 24 hours after the intervention;

Countries

China

Contacts

Public ContactZiwen Chen

Foshan Traditional Chinese Medicine Hospital

303643695@qq.com+86 178 1780 4707

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026